Literature DB >> 23250287

Investigation of Zr(IV) and 89Zr(IV) complexation with hydroxamates: progress towards designing a better chelator than desferrioxamine B for immuno-PET imaging.

François Guérard1, Yong-Sok Lee, Raphaël Tripier, Lawrence P Szajek, Jeffrey R Deschamps, Martin W Brechbiel.   

Abstract

Single crystal X-ray diffraction shows that Zr(iv) forms an octa-coordinated complex with 4 bidentate hydroxamates whose solution structures were investigated by utilizing density functional theory at the level of B3LYP/DGDZVP. Stability constants obtained by potentiometry were in accordance with the tendency observed when radiolabeling with (89)Zr.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23250287      PMCID： PMC3538910          DOI： 10.1039/c2cc37549d

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  10 in total

Review 1.  PET tracers based on Zirconium-89.

Authors:  Yin Zhang; Hao Hong; Weibo Cai
Journal:  Curr Radiopharm       Date:  2011-04

2.  Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET.

Authors:  Jeff N Tinianow; Herman S Gill; Annie Ogasawara; Judith E Flores; Alexander N Vanderbilt; Elizabeth Luis; Richard Vandlen; Martine Darwish; Jagath R Junutula; Simon-P Williams; Jan Marik
Journal:  Nucl Med Biol       Date:  2010-02-10       Impact factor: 2.408

3.  PET and MRI of metastatic peritoneal and pulmonary colorectal cancer in mice with human epidermal growth factor receptor 1-targeted 89Zr-labeled panitumumab.

Authors:  Tapan K Nayak; Kayhan Garmestani; Diane E Milenic; Martin W Brechbiel
Journal:  J Nucl Med       Date:  2012-01       Impact factor: 10.057

4.  Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibody.

Authors:  Catharina M van Rij; Robert M Sharkey; David M Goldenberg; Cathelijne Frielink; Janneke D M Molkenboer; Gerben M Franssen; Wietske M van Weerden; Wim J G Oyen; Otto C Boerman
Journal:  J Nucl Med       Date:  2011-08-24       Impact factor: 10.057

Review 5.  Radiopharmaceutical chemistry with iodine-124: a non-standard radiohalogen for positron emission tomography.

Authors:  Ann-Marie Chacko; Chaitanya R Divgi
Journal:  Med Chem       Date:  2011-09       Impact factor: 2.745

6.  89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo.

Authors:  Jason P Holland; Vadim Divilov; Neil H Bander; Peter M Smith-Jones; Steven M Larson; Jason S Lewis
Journal:  J Nucl Med       Date:  2010-07-21       Impact factor: 10.057

7.  Solution structures of the prototypical 18 kDa translocator protein ligand, PK 11195, elucidated with 1H/13C NMR spectroscopy and quantum chemistry.

Authors:  Yong-Sok Lee; Fabrice G Siméon; Emmanuelle Briard; Victor W Pike
Journal:  ACS Chem Neurosci       Date:  2012-02-14       Impact factor: 4.418

8.  89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.

Authors:  Iris Verel; Gerard W M Visser; Ronald Boellaard; Marijke Stigter-van Walsum; Gordon B Snow; Guus A M S van Dongen
Journal:  J Nucl Med       Date:  2003-08       Impact factor: 10.057

9.  Modular strategy for the construction of radiometalated antibodies for positron emission tomography based on inverse electron demand Diels-Alder click chemistry.

Authors:  Brian M Zeglis; Priya Mohindra; Gabriel I Weissmann; Vadim Divilov; Scott A Hilderbrand; Ralph Weissleder; Jason S Lewis
Journal:  Bioconjug Chem       Date:  2011-09-20       Impact factor: 4.774

10.  p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging.

Authors:  Lars R Perk; Maria J W D Vosjan; Gerard W M Visser; Marianne Budde; Paul Jurek; Garry E Kiefer; Guus A M S van Dongen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-18       Impact factor: 9.236
  10 in total
  38 in total

1.  Synthesis and Evaluation of a Zr-89-Labeled Monoclonal Antibody for Immuno-PET Imaging of Amyloid-β Deposition in the Brain.

Authors:  Jens Fissers; Ann-Marie Waldron; Thomas De Vijlder; Bianca Van Broeck; Darrel J Pemberton; Marc Mercken; Pieter Van Der Veken; Jurgen Joossens; Koen Augustyns; Stefanie Dedeurwaerdere; Sigrid Stroobants; Steven Staelens; Leonie Wyffels
Journal:  Mol Imaging Biol       Date:  2016-08       Impact factor: 3.488

2.  Macrocycle-Based Hydroxamate Ligands for Complexation and Immunoconjugation of 89Zirconium for Positron Emission Tomography (PET) Imaging.

Authors:  Eszter Boros; Jason P Holland; Nathaniel Kenton; Nicholas Rotile; Peter Caravan
Journal:  Chempluschem       Date:  2016-01-25       Impact factor: 2.863

Review 3.  In vivo imaging with antibodies and engineered fragments.

Authors:  Amanda C Freise; Anna M Wu
Journal:  Mol Immunol       Date:  2015-04-28       Impact factor: 4.407

Review 4.  Progress of Coordination and Utilization of Zirconium-89 for Positron Emission Tomography (PET) Studies.

Authors:  Minh Thanh La; Van Hieu Tran; Hee-Kwon Kim
Journal:  Nucl Med Mol Imaging       Date:  2019-01-29

5.  Investigation of the complexation of natZr(iv) and 89Zr(iv) by hydroxypyridinones for the development of chelators for PET imaging applications.

Authors:  F Guérard; M Beyler; Y-S Lee; R Tripier; J-F Gestin; M W Brechbiel
Journal:  Dalton Trans       Date:  2017-04-05       Impact factor: 4.390

6.  Multifunctional Desferrichrome Analogues as Versatile 89Zr(IV) Chelators for ImmunoPET Probe Development.

Authors:  Casey J Adams; Justin J Wilson; Eszter Boros
Journal:  Mol Pharm       Date:  2017-07-19       Impact factor: 4.939

7.  Evaluation of cetuximab as a candidate for targeted α-particle radiation therapy of HER1-positive disseminated intraperitoneal disease.

Authors:  Diane E Milenic; Kwamena E Baidoo; Young-Seung Kim; Martin W Brechbiel
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 8.  The chemical biology and coordination chemistry of putrebactin, avaroferrin, bisucaberin, and alcaligin.

Authors:  Rachel Codd; Cho Zin Soe; Amalie A H Pakchung; Athavan Sresutharsan; Christopher J M Brown; William Tieu
Journal:  J Biol Inorg Chem       Date:  2018-06-26       Impact factor: 3.358

9.  The bioconjugation and radiosynthesis of 89Zr-DFO-labeled antibodies.

Authors:  Brian M Zeglis; Jason S Lewis
Journal:  J Vis Exp       Date:  2015-02-12       Impact factor: 1.355

10.  Rational design, synthesis, and evaluation of tetrahydroxamic acid chelators for stable complexation of zirconium(IV).

Authors:  François Guérard; Yong-Sok Lee; Martin W Brechbiel
Journal:  Chemistry       Date:  2014-04-16       Impact factor: 5.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.